[1]
“Tolerability, safety and efficacy of Iloprost infusion without peristaltic pump in systemic sclerosis”, Reumatismo, vol. 53, no. 2, pp. 140–144, Jun. 2001, doi: 10.4081/reumatismo.2001.140.